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BRIEF COMMUNICATION
Since the introduction of percutaneous endoscopic
gastrostomy (PEG) into clinical practice by Ponsky
and Gauderer,1 it has gained wide popularity and
has become the procedure of choice for long-term
nutritional support in patients who cannot swal-
low but have intact gut function.2–5 The usual
indications are neurologic and oropharyngeal dis-
order.2,6–8 Although we encounter many such pa-
tients in daily practice, PEG is still not very popular
in Taiwan, probably due to education and reim-
bursement problems. Here, we present our expe-
rience with 310 Taiwanese patients who underwent
PEG, and discuss the success rate, indications and
complications of this procedure.
Materials and Methods
Between May 1997 and May 2005, we performed
302 PEG procedures at National Taiwan University
Hospital, Taipei Hospital and Far Eastern Memorial
Hospital. We used modified Ponsky’s pull method1
with 24-Fr feeding tubes (PEG-24-Pull; Wilson-
Cook Medical Inc., Winston-Salem, NC, USA).
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Ponsky’s pull method with 24-Fr feeding tubes. All the patients received PEG for tube feeding except for
two patients with cancerous peritonitis for decompression. The underlying diseases in these 308 patients
who received PEG for tube feeding were 161 cerebrovascular accidents (52.3%), 62 head and neck cancers
(20.1%), 21 cases of Parkinsonism (6.8%), and others. There were 11 major complications (3.6%) and 
57 minor complications (18.9%). Ten patients (3.3%) died within 30 days after PEG insertion. However,
no procedure-related mortality occurred. In conclusion, PEG is an effective method for tube feeding and
drainage with a high success rate. PEG insertion was often indicated for patients with dysphagia caused by
cerebrovascular accident, head and neck cancer, and Parkinsonism in Taiwan. It is a relatively safe proce-
dure, with a 3.6% rate of major complications and 18.9% rate of minor complications. [J Formos Med Assoc
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We gave 25–50 mg meperidine intramuscularly to
each patient before the procedure. We used trans-
illumination and indentation methods3,7 to iden-
tify a suitable puncture site. After skin preparation
and local anesthesia, we made a 1-cm incision over
the selected site and put the guide wire into the
stomach, then brought it out of the mouth by the
snare. We tied the tube on the wire and pulled it
through the mouth into the stomach and then
outside the abdomen. We left a 0.5-cm space 
between the external bolster and skin initially to
avoid over-tightness. We opened the feeding tube
for drainage for 24 hours and started to feed the
patient from the 2nd day. We administered 1 g
cephalothin intravenously 30 minutes before the
procedure for each patient.
Results
There were 211 male and 99 female patients (mean
age, 70.1 years; age range, 15–103 years) who re-
ceived PEG insertion in National Taiwan University
Hospital, Taipei Hospital, and Far Eastern Memo-
rial Hospital. We performed 302 PEG insertions
successfully in 310 attempts (97.4% success rate).
PEG insertion was unsuccessful in four cases where
no suitable puncture site could be found, in three
due to failure to pass the scope into the stomach,
and in one due to cardiopulmonary instability
during the procedure. All received PEG for tube
feeding except for two patients with cancerous peri-
tonitis for decompression. The primary malignan-
cies of these two patients were gastric cancer and
renal transitional cell carcinoma. The underlying
diseases in the 308 cases who received PEG for tube
feeding are shown in Table 1. Only seven cerebro-
vascular accident (CVA) patients received PEG in-
sertion within 1 month of onset. Forty-two out of
62 patients with head and neck cancers received
PEG insertion due to the late effect of radiotherapy.
Among the 302 successful PEG insertions, there
were 19 patients with gastric ulcer, seven with gas-
tric cancer, five with previous PEG wound, one with
previous surgical gastrostomy wound, and 10 with
ventriculoperitoneal shunt that did not preclude
PEG insertion. Most of the patients with gastric
cancer received PEG insertion due to concomitant
neurologic dysphagia. Five of eight patients with
partial gastrectomy had successful PEG insertion.
There were two patients with esophageal cancer
and one with gastric cardiac cancer who needed
through-the-scope balloon dilatation before PEG
insertion and one with corrosive stricture who
needed Savary-Guilliard dilatation.
There were 11 major complications (3.6%), in-
cluding one patient with suspected peritonitis who
received surgical laparotomy within 1 day, one pa-
tient who developed atrial fibrillation with rapid
ventricular response and needed to be transferred
to the intensive care unit on the same day of PEG
insertion, and nine cases of aspiration pneumo-
nia (Table 2). There were 57 minor complications
(18.9%), including 21 wound infections, nine cases
of gastroparesis that interfered with feeding, and
four incidental extubation within 1 month (Table
2.). Ten patients (3.3%) died within 30 days after
PEG insertion. However, there was no procedure-
related mortality.
After PEG insertion, the feeding tube needs to
be replaced if it is deformed, broken, clogged or
removed inadvertently. Most of our patients re-
ceived PEG replacement about 1 year after inser-
tion of PEG-24-Pull tube; the time ranged from 
6 months to 18 months depending on the manip-
ulation of the tube and feeding content. Most of
Table 1. Underlying diseases in the 308 patients
who received percutaneous endoscopic
gastrostomy (PEG) insertion for tube
feeding
Underlying disease for PEG insertion n (%)
Cerebrovascular accident 161 (52.3)
Head and neck cancer 62 (20.1)
Parkinsonism 21 (6.8)
Dementia 13 (4.2)
Motor neuron disease 12 (3.9)
Hypoxic encephalopathy 9 (2.9)
Head injury 8 (2.6)
Central nervous system 7 (2.3)
degenerative disease
Other 15 (4.9)
our patients received PEG replacement using PEG-
24-Pull tube with endoscopic assistance instead
of balloon replacement tube because the former
tube is more pliable and durable. The gastrostomy
can be used with repeated tube replacement and it
can close after tube removal if the patient regains
swallowing ability. In our series, the longest du-
ration of PEG feeding was more than 8 years in
one patient with old CVA, and the shortest dura-
tion was 3 months in a patient with hypopharyn-
geal cancer preparing for chemoradiation therapy.
Discussion
Enteral nutrition is the preferred route for nutri-
tional support compared with parenteral nutrition
if the gastrointestinal tract is functionally pre-
served.9,10 Nasogastric tubes have the advantage
of being simple to insert, but are not well toler-
ated by patients and have some complications in
long-term use. Since the introduction of PEG by
Ponsky and Gauderer in 1981,1 it has proven to be
a fast and safe procedure and has become the most
popular way of establishing long-term tube feed-
ing.2,7,9,11,12 However, PEG is not popular in Taiwan
and there are only a few reports on its application
in Taiwan.13–15
Similar to previous reports,2,6,7,16 the majority
of the underlying diseases in our patients who re-
ceived PEG insertion were neurologic disorders, in-
cluding CVA, Parkinsonism, motor neuron disease,
hypoxic encephalopathy, head injury and degen-
erative diseases. Most of our patients with CVA
received PEG at a later stage, and only seven out
of 157 cases were performed within 1 month of
onset. Head and neck cancers are also important
diseases for PEG insertion.3,17 However, unlike pre-
viously reported series, the majority of our patients
received PEG insertion due to the late effect of ra-
diotherapy. These patients occasionally have some
radiation-induced problems that interfere with en-
doscopic examination, such as trismus or pharyn-
geal stricture. In our series, PEG was also performed
for tube feeding in two patients with esophageal
cancer and one with gastric cardiac cancer. It is an
alternative to expensive metallic stent insertion.
PEG is also an alternative to the nasogastric tube
as a means of gastrointestinal decompression.
Only two of our patients received PEG insertion
for decompression due to cancerous peritonitis.
The reported success rate of PEG insertion is
high, usually more than 95%.2,3,18 Our series also
had a comparable success rate (97.4%). There are
some situations that may interfere with PEG inser-
tion. We attempted PEG insertion in eight patients
with partial gastrectomy and were successful in five,
but three patients had the tube puncture through
the intestinal wall near the anastomotic site. Four
patients with malignant or benign stricture received
PEG insertion after endoscopic or radiologic guided
dilatation. Ten patients with ventriculoperitoneal
shunt received PEG insertion and were discharged
smoothly. Schulman and Sawyer had reported 
a similar result in 2005.19 In our series, there were
19 patients with gastric ulcer, seven with gastric can-
cer and six with previous PEG or surgical gastros-
tomy wound that did not preclude PEG insertion.
PEG insertion was associated with some com-
plications. The rate of major complications that
cause significant morbidity is reported to range
from 3% to 12%, including perforation, major
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Table 2. Complications associated with 302
successful percutaneous endoscopic
gastrostomy insertions
n (%)
Major complications 11 (3.6)
Aspiration pneumonia 9
Suspected peritonitis 1
Atrial fibrillation 1
Minor complications 57 (18.9)
Wound infection 21
Gastroparesis 9
Peristomal leakage 7
Upper gastrointestinal bleeding 6
Stomal bleeding 4
Incidental extubation 4
Diarrhea 3
Abdominal wall hematoma 1
Severe wound pain 1
Tube blockage 1
bleeding, aspiration pneumonia, and necrotizing
fasciitis.2–4,7,20 There were 11 (3.6%) major com-
plications in our series, and most were aspiration
pneumonia. It was probably due to lack of ade-
quate assistants for frequent suction of oropha-
ryngeal secretion of the patients in supine position
during the procedure. The minor complication rate
is reported to range from 10% to 40% and varies
with different definitions, including minor bleed-
ing, wound infection, peristomal leakage, tube dys-
function, ileus, and complications associated with
feeding.2–4,18,20 The 30-day post-PEG mortality rate
in our series was 3.3%, which is lower than the
4.1–26.1% reported in the literature.2,4,21,22 It was
probably because relatively few patients with CVA
received PEG insertion in the acute stage and many
of the patients with head and neck cancer received
PEG insertion at a later stage after effective radio-
therapy. From the literature, the mortality rate 
of patients receiving PEG insertion with comor-
bidities stabilizes 2 months later after the acute
episode.22,23 So we would recommend PEG in-
sertion for patients who require tube feeding for
more than 3 months, otherwise nasogastric tube
can provide a convenient route for short-term
nutritional support.
Apart from endoscopic guidance, percutaneous
fluoroscopic gastrostomy is another effective and
safe approach for insertion of feeding tube.24–26
However, the inserted feeding tubes are usually
smaller than that via the endoscopic route (12–18
Fr vs. 24 Fr). Most Taiwanese patients or caregivers
prefer larger tubes for convenience of bolus feed-
ing. Under rare circumstances, other modalities
of examination can provide supplemental moni-
toring for facilitation of PEG insertion, including
transabdominal ultrasonography,27,28 endoscopic
ultrasonography,29 computed tomography28 and
laparoscopy.30
In conclusion, PEG is an effective method for
tube feeding and drainage with a high success
rate. PEG insertion is indicated for patients with
dysphagia caused by CVA, head and neck cancer
and Parkinsonism in Taiwan. It is a relatively safe
procedure with a 3.6% rate of major complica-
tions and an 18.9% rate of minor complications.
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